J. Goldman & Co’s Vera Therapeutics VERA Stock Holding History

J. Goldman & Co’s Portfolio VERA Stock Details VERA Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2024 Q3	–	Sell	-6,800	Closed	-$246K	–	631
2024 Q2	$246K	Sell	6,800 -23,381	-77%	-$927K	0.01%	397
2024 Q1	$1.3M	Buy	+30,181	New	+$1.08M	0.04%	248

Other funds holding VERA

ACA

Avoro Capital Advisors New York $10.2B AUM 149.19% 1-Year Est. Return

T. Rowe Price Associates Baltimore, Maryland $865B AUM 30.76% 1-Year Est. Return

BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return

Sofinnova Investments Menlo Park, California $2.63B AUM 117.41% 1-Year Est. Return

Fidelity Investments Boston, Massachusetts $1.9T AUM 41.92% 1-Year Est. Return

Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return

Commodore Capital New York $1.73B AUM 298.96% 1-Year Est. Return

Eversept Partners New York $1.9B AUM 121.13% 1-Year Est. Return

Holocene Advisors New York $41.5B AUM 42.97% 1-Year Est. Return

State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return

J. Goldman & Co's VERA Position: Q3 2024 in Review

J. Goldman & Co sold out of Vera Therapeutics (VERA) in Q3 2024, closing a stake of 6,800 shares — an estimated $246K sold.

J. Goldman & Co first reported a position in VERA in Q1 2024 and held it in 2 quarters. The position peaked at $1.3M in Q1 2024. 173 funds tracked by Wall St. Rank hold VERA as of Q3 2024.

J. Goldman & Co reported no remaining Vera Therapeutics position as of Q3 2024 after selling out during the quarter.
J. Goldman & Co sold 6,800 Vera Therapeutics shares in Q3 2024, an estimated $246K.
J. Goldman & Co first reported a position in Vera Therapeutics in Q1 2024 and held it in 2 quarters.
J. Goldman & Co's Vera Therapeutics position peaked at $1.3M in Q1 2024.
173 funds tracked by Wall St. Rank held Vera Therapeutics as of Q3 2024.

Based on J. Goldman & Co's 13F filing for Q3 2024, filed 14 Nov 2024.